Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-06

FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for ALENDRONATE SODIUM from Aurobindo Pharma Limited, enabling the approved generic formulation to be marketed with the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALENDRONATE SODIUM (ALENDRONATE SODIUM)

Snippet

SUPPL AP for ALENDRONATE SODIUM (ALENDRONATE SODIUM)